Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32

被引:13
作者
Takagi, Kohji [1 ]
Imura, Johji [1 ]
Shimomura, Akiko [1 ]
Noguchi, Akira [1 ]
Minamisaka, Takashi [1 ]
Tanaka, Shinichi [1 ]
Nishida, Takeshi [1 ]
Hatta, Hideki [1 ]
Nakajima, Takahiko [1 ]
机构
[1] Univ Toyama, Acad Assembly, Fac Med, Dept Diagnost Pathol, 2630 Sugitani, Toyama, Toyama 9300194, Japan
基金
日本学术振兴会;
关键词
pancreatic cancer cell; invasion; comprehensive genomic analysis; cell culture; interleukin-32; INTERLEUKIN-32; PROGRESSION; GENE;
D O I
10.3892/ol.2020.11825
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Compared to tumors of other organs, pancreatic cancer is highly aggressive; with one of its biological features being that, despite a prominent fibrotic stroma, there is remarkable infiltration of tumor cells. This characteristic is considered to be the main reason for the poor prognosis of patients with pancreatic cancer. Therefore, in order to elucidate the factors that contribute to this high invasiveness, a selective invasion method was used to establish four highly invasive subclones from six human pancreatic cancer cell lines. The results demonstrated that two cell lines did not exhibit enhanced invasiveness. Microarray analysis revealed that, in the highly invasive cell lines, several genes were expressed at high levels, compared with the original cell lines. These highly expressed genes were recognized only in highly invasive cells. Among them,IL-32was most strongly upregulated in the highly invasive cells, compared with cells with a low invasive potential, as well as the original cells. RT-qPCR and western blot analysis confirmed the high levels of expression of IL-32 in highly invasive cells at the RNA and protein levels. In addition, immunohistochemical analysis of resected surgical materials revealed that the tumor cells expressed IL-32 and, in particular, many IL-32 positive cells were seen at the invasive front of the tumor tissue. IL-32 is a cytokine that is widely involved in the development of cancer and has recently received considerable attention. This cytokine has multiple splice variants and shows a wide variety of behaviors, depending on the tumor type and primary organ. Although some hypotheses have been proposed to explain the activity of IL-32, a unified view has not been agreed. In the present study, through the establishment of highly invasive cells from pancreatic cancer and a comprehensive gene analysis, it is suggested that IL-32 may serve an important role as a molecule involved in the invasiveness of this neoplasm.
引用
收藏
页码:2888 / 2896
页数:9
相关论文
共 50 条
  • [21] Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis
    Alsaleh, Ghada
    Sparsa, Laetitia
    Chatelus, Emmanuel
    Ehlinger, Mathieu
    Gottenberg, Jacques-Eric
    Wachsmann, Dominique
    Sibilia, Jean
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (04)
  • [22] Expression of IL-32 modulates NF-κB and p38 MAP kinase pathways in human esophageal cancer
    Yousif, Nasser Ghaly
    Al-amran, Fadhil G.
    Hadi, Najah
    Lee, Jillen
    Adrienne, Jonthan
    CYTOKINE, 2013, 61 (01) : 223 - 227
  • [23] Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss
    Zahoor, Muhammad
    Westhrin, Marita
    Aass, Kristin Roseth
    Moen, Siv Helen
    Misund, Kristine
    Psonka-Antonczyk, Katarzyna Maria
    Giliberto, Mariaserena
    Buene, Glenn
    Sundan, Anders
    Waage, Anders
    Sponaas, Anne-Marit
    Standal, Therese
    BLOOD ADVANCES, 2017, 1 (27) : 2656 - 2666
  • [24] Overexpression of IL-32 is a novel prognostic factor in patients with localized clear cell renal cell carcinoma
    Lee, Hyun-Jung
    Liang, Zhe Long
    Huang, Song Mei
    Lim, Jae-Sung
    Yoon, Do-Young
    Lee, Hyo-Jin
    Kim, Jin Man
    ONCOLOGY LETTERS, 2012, 3 (02) : 490 - 496
  • [25] IL-32γ promotes integrin αvβ6 expression through the activation of NF-κB in HSCs
    Liu, Hongcan
    Pan, Xingfei
    Cao, Hong
    Shu, Xin
    Sun, Haixia
    Lu, Jianxi
    Liang, Jiayin
    Zhang, Ka
    Zhu, Fengqin
    Li, Gang
    Zhang, Qi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (04) : 3880 - 3886
  • [26] Establishment and Characterization of a Highly Tumourigenic and Cancer Stem Cell Enriched Pancreatic Cancer Cell Line as a Well Defined Model System
    Fredebohm, Johannes
    Boettcher, Michael
    Eisen, Christian
    Gaida, Matthias M.
    Heller, Anette
    Keleg, Shereen
    Tost, Joerg
    Greulich-Bode, Karin M.
    Hotz-Wagenblatt, Agnes
    Lathrop, Mark
    Giese, Nathalia A.
    Hoheisel, Joerg D.
    PLOS ONE, 2012, 7 (11):
  • [27] IL-32γ suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated STAT5 pathway
    Lee, Yong Sun
    Kim, Ki Cheon
    Mongre, Raj Kumar
    Kim, Ji Young
    Kim, Yu Ri
    Choi, Dong Young
    Song, Sukgil
    Yun, Jaesuk
    Han, Sang-Bae
    Yoon, Do Young
    Hong, Jin Tae
    CELL DEATH & DISEASE, 2019, 10 (7)
  • [28] Significant association between IL-32 gene polymorphisms and susceptibility to endometrial cancer in Chinese Han women
    Yu, Xiuzhang
    Zhou, Bin
    Zhang, Zhu
    Gao, Qianqian
    Wang, Yanyun
    Song, Yaping
    Pu, Yan
    Chen, Yue
    Duan, Ruiqi
    Zhang, Lin
    Xi, Mingrong
    TUMOR BIOLOGY, 2015, 36 (07) : 5265 - 5272
  • [29] IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling
    Yun, Hyung-Mun
    Park, Kyung-Ran
    Kim, Eun-Cheol
    Han, Sang Bae
    Yoon, Do Young
    Hong, Jin Tae
    ONCOTARGET, 2015, 6 (11) : 9061 - 9072
  • [30] IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1
    Kim, Man Sub
    Kang, Jeong-Woo
    Park, Yun Sun
    Lee, Dong Hun
    Bak, Yesol
    Kwon, Taeho
    Yoon, Do-Young
    ONCOTARGET, 2015, 6 (06) : 4394 - 4405